NM_004370.6:c.8265+19A>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004370.6(COL12A1):c.8265+19A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0399 in 1,596,606 control chromosomes in the GnomAD database, including 4,848 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 2029 hom., cov: 32)
Exomes 𝑓: 0.033 ( 2819 hom. )
Consequence
COL12A1
NM_004370.6 intron
NM_004370.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0960
Publications
1 publications found
Genes affected
COL12A1 (HGNC:2188): (collagen type XII alpha 1 chain) This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
COL12A1 Gene-Disease associations (from GenCC):
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Illumina, Genomics England PanelApp
- Ullrich congenital muscular dystrophy 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-75105187-T-A is Benign according to our data. Variant chr6-75105187-T-A is described in ClinVar as Benign. ClinVar VariationId is 259350.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.109 AC: 16509AN: 152052Hom.: 2016 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16509
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0629 AC: 15437AN: 245468 AF XY: 0.0562 show subpopulations
GnomAD2 exomes
AF:
AC:
15437
AN:
245468
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0326 AC: 47117AN: 1444436Hom.: 2819 Cov.: 27 AF XY: 0.0321 AC XY: 23124AN XY: 719582 show subpopulations
GnomAD4 exome
AF:
AC:
47117
AN:
1444436
Hom.:
Cov.:
27
AF XY:
AC XY:
23124
AN XY:
719582
show subpopulations
African (AFR)
AF:
AC:
10289
AN:
32958
American (AMR)
AF:
AC:
3241
AN:
44008
Ashkenazi Jewish (ASJ)
AF:
AC:
1340
AN:
25856
East Asian (EAS)
AF:
AC:
6671
AN:
39564
South Asian (SAS)
AF:
AC:
3945
AN:
85190
European-Finnish (FIN)
AF:
AC:
866
AN:
53254
Middle Eastern (MID)
AF:
AC:
281
AN:
5726
European-Non Finnish (NFE)
AF:
AC:
17283
AN:
1098186
Other (OTH)
AF:
AC:
3201
AN:
59694
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2046
4091
6137
8182
10228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
952
1904
2856
3808
4760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.109 AC: 16553AN: 152170Hom.: 2029 Cov.: 32 AF XY: 0.108 AC XY: 8054AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
16553
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
8054
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
12377
AN:
41450
American (AMR)
AF:
AC:
1279
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
143
AN:
3468
East Asian (EAS)
AF:
AC:
967
AN:
5172
South Asian (SAS)
AF:
AC:
247
AN:
4824
European-Finnish (FIN)
AF:
AC:
151
AN:
10616
Middle Eastern (MID)
AF:
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1170
AN:
68028
Other (OTH)
AF:
AC:
196
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
636
1272
1909
2545
3181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
458
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.